MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progenies
- 19 March 2010
- journal article
- Published by Elsevier BV in Cancer Letters
- Vol. 295 (1), 69-84
- https://doi.org/10.1016/j.canlet.2010.02.015
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Pancreatic cancer cells resistance to gemcitabine: the role of MUC4 mucinBritish Journal of Cancer, 2009
- The Membrane Mucin Muc4 Inhibits Apoptosis Induced by Multiple Insults via ErbB2-Dependent and ErbB2-Independent MechanismsCancer Research, 2009
- Upregulation of MUC4 in Cervical Squamous Cell Carcinoma: Pathologic SignificanceInternational Journal of Gynecological Pathology, 2009
- MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cellsBritish Journal of Cancer, 2008
- Recent progress on normal and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancerGut, 2008
- Structure, evolution, and biology of the MUC4 mucinThe FASEB Journal, 2007
- Advances in counselling and surveillance of patients at risk for pancreatic cancerGut, 2007
- Human MUC4 mucin induces ultra-structural changes and tumorigenicity in pancreatic cancer cellsBritish Journal of Cancer, 2007
- Gene expression analysis for predicting gemcitabine sensitivity in pancreatic cancer patientsHPB, 2007
- Muc4–ErbB2 Complex Formation and Signaling in Polarized CACO-2 Epithelial Cells Indicate That Muc4 Acts as an Unorthodox Ligand for ErbB2Molecular Biology of the Cell, 2006